SOPHiA GENETICS SA Stock (NASDAQ:SOPH)
Previous Close
$3.53
52W Range
$2.70 - $7.37
50D Avg
$3.64
200D Avg
$4.37
Market Cap
$215.74M
Avg Vol (3M)
$37.71K
Beta
1.03
Div Yield
-
SOPH Company Profile
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
SOPH Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
Annual
| Product/Service | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|
| North America | $10.73M | $6.73M | - |
| UNITED STATES | $9.46M | $3.94M | - |
| SWITZERLAND | $1.43M | $1.39M | - |
| SPAIN | $6.51M | $3.77M | - |
| Asia Pacific | $3.70M | $2.95M | - |
| Europe, The Middle East And Africa | $43.96M | $34.88M | - |
| FRANCE | $10.08M | $7.41M | - |
| ITALY | $8.55M | $6.12M | - |
| Latin America | $3.99M | $3.00M | - |
| AUSTRIA | - | - | $1.83M |
| BRAZIL | - | - | $1.62M |
| GERMANY | - | - | $1.28M |
| Other Country | - | - | $8.90M |
| TURKEY | - | - | $2.68M |
Latest
Fiscal year ends in Dec 23 | Currency in USD